Joslin Diabetes Center International Symposium on October 07-09, 2025 in Boston, United States

2025 Joslin International Symposium

This year's symposium's theme is "Inter-Organ Communication in the Pathogenesis and Treatment of Diabetes and Obesity." It will bring together world-renowned investigators to explore the complex metabolic interactions among key organs- liver, brain, gut, pancreas, and adipose tissue. Through keynote lectures, focused sessions, and lively discussions, the program will highlight the latest advances in understanding the hormonal, neuronal, and molecular signals that govern systemic metabolism, aiming to identify novel therapeutic targets for diabetes, obesity, and related cardiometabolic disorders.

2025 Symposium Overview

The Joslin Diabetes Center, in collaboration with the Steno Diabetes Center and the Banting and Best Diabetes Centre, is proud to present the 2025 Joslin International Symposium, taking place October 7-9, 2025 at the Joseph B. Martin Conference Center at Harvard Medical School.

This course is designed for a broad audience of basic scientists, translational investigators, clinicians, and industry partners who are engaged in diabetes, obesity, metabolism, and endocrine research and care.

Program Highlights

Keynote lectures by internationally renowned leaders in metabolism, including Lottie Bjerre-Knudsen (Novo Nordisk) and Philipp Scherer (UT Southwestern)

Metabolic messengers and organ crosstalk: how endocrine, neuronal, and paracrine signals connect organ systems in diabetes and obesity

Liver-centered metabolic regulation and its role in whole-body glucose and lipid homeostasis

Endocrine pancreas cross talk with metabolic tissues to regulate glucose homeostasis

Gut-microbiome interactions in systemic metabolism and their therapeutic potential

Adipose tissue as an active endocrine organ and its communication with the brain, liver, and immune system

Central nervous system regulation of appetite, energy balance, and glucose metabolism

Genetic and epigenetic mechanisms contributing to metabolic disease risk and heterogeneity

Cutting-edge short talks from rising investigators and trainees

Poster session and evening networking reception with international faculty and peers

Collaborative insight from Joslin Diabetes Center, Steno Diabetes Center, and Banting and Best Diabetes Centre

Who Should Attend

This symposium is designed for a multidisciplinary audience of professionals seeking a deeper understanding of the evolving science behind systemic metabolism and organ crosstalk.. Attendees will include:

Basic scientists studying metabolic pathways and inter-organ signaling

Translational investigators working to bridge laboratory discoveries with clinical applications

Clinicians involved in the care of patients with diabetes and endocrine disorders

Industry partners developing therapeutics or diagnostics in metabolism and endocrinology

This program is designed to enhance knowledge across basic, translational, and clinical domains-empowering participants to integrate new insights into research, innovation, and patient care.

Learning Objectives

The fields of diabetes, obesity, and metabolic research are undergoing rapid and transformative change. With the increasing understanding of inter-organ communication-spanning hormonal, neuronal, and molecular pathways-clinicians and scientists are redefining how metabolic diseases are studied and treated. This symposium brings together world-class experts from academia, medicine, and industry to share emerging insights and therapeutic strategies.

Upon completion of this activity, participants will be able to:

Describe the mechanisms of inter-organ metabolic crosstalk and their implications for diabetes and obesity.

Evaluate the role of the liver, gut microbiome, adipose tissue, brain, and pancreas in systemic glucose and energy regulation.

Interpret cutting-edge findings in epigenetics and transcriptomics as they relate to metabolic disease progression and risk stratification.

Identify emerging biomarkers and molecular messengers as potential therapeutic targets.

This program is designed to enhance knowledge across basic, translational, and clinical domains-empowering participants to integrate new insights into research, innovation, and patient care.

URLs:

Tickets: https://go.evvnt.com/3156251-0?pid=10008

Website: https://go.evvnt.com/3156251-3?pid=10008

Website: https://go.evvnt.com/3156251-4?pid=10008

Website: https://go.evvnt.com/3156251-5?pid=10008

Website: https://go.evvnt.com/3156251-6?pid=10008

Inquiries: https://go.evvnt.com/3156251-7?pid=10008

Facebook: https://go.evvnt.com/3156251-8?pid=10008

Twitter: https://go.evvnt.com/3156251-9?pid=10008

Instagram: https://go.evvnt.com/3156251-10?pid=10008

LinkedIn: https://go.evvnt.com/3156251-11?pid=10008

Time: 2:00 PM - 11:45 AM

Prices:

Academics: USD 500.00,

Trainees, Fellows and Students: USD 150.00,

Harvard-affiliated Faculty/Fellows/Students: USD 0.00,

Industry: USD 850.00

Speakers: Lotte Bjerre Knudsen, DMSc, Phillip Scherer, PhD, Domenico Accili, MD, Alejandro Caicedo-Vierkant, PhD, Christoffer Clemmensen, PhD, Paul Cohen, MD, PhD, Anthony Ferrante, MD, PhD, Barbara Kahn, MD, C Ronald Kahn, MD, Aleksandar Kostic, PhD, Tony Lam, PhD, Mitchell A Lazar, MD, PhD, Jonathan Long, MD, Ruth Loos, MD, Bradford Lowell, MD, PhD, Elefheria Maratos-Flier, MD, Umut Ozcan, MD, Joshua Rabinowitz, Darleen Sandoval, PhD, Ferdinand von Meyenn, MD, Minna Woo, MD, PhD, Rohit Kulkarni, MD, PhD, Mary-Elizabeth Patti, MD, Yu-Hua Tseng, PhD, George King, MD